Technology Development for the Synthesis of S-Amlodipine Nicotinate Drug Substance


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Technology for the synthesis of S-amlodipine nicotinate drug substance was developed based on an acceptable method of effective separation of the amlodipine optical isomers. A literature review suggested that the most promising methods employed 2-propanol (pure or with small additions of cosolvents) as the main solvent. However, experiments showed that the optimum solvent was DMSO. The proposed synthesis of S-amlodipine nicotinate drug substance was confirmed to be stable and reproducible. Standardization methods were developed.

Sobre autores

G. Kim

All-Russia Scientific Center for Safety Testing of Biologically Active Substances, Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Rússia, 23 Kirova St., Staraya Kupavna, Moscow Oblast, 142450

Zh. Kozlova

I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Rússia, 2/4 Bol’shaya Pirogovskaya St., Moscow, 119991

S. Pchelintsev

I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Rússia, 2/4 Bol’shaya Pirogovskaya St., Moscow, 119991

R. Savel’yanova

EcoChem-Innovations

Email: chem@folium.ru
Rússia, 8 Druzhby St., Novomoskovsk, Tula Oblast, 301650

N. Berezina

EcoChem-Innovations

Email: chem@folium.ru
Rússia, 8 Druzhby St., Novomoskovsk, Tula Oblast, 301650

I. Krasnyuk

I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Rússia, 2/4 Bol’shaya Pirogovskaya St., Moscow, 119991

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media New York, 2017